Open Access

Expression and clinical significance of Oct‑4 and E‑cad in non‑small‑cell lung cancer

  • Authors:
    • Li Li
    • Yanling Lv
    • Ying Zhang
    • Liya He
    • Hongzhen Zhang
  • View Affiliations

  • Published online on: November 4, 2015     https://doi.org/10.3892/ol.2015.3856
  • Pages: 234-236
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Non‑small‑lung cancer (NSCLC) is a common malignant tumor and is a leading cause of cancer mortality. Tumor stem cells are associated with tumor pathogenesis and development as well as invastion and metastasis. In the present study, the expression and correlation of tumor stem cell markers, octamer‑binding transcription factor 4 (Oct‑4) and E‑cadherin (E‑cad) in NSCLC and normal lung tissue were investigated. Additionally, the molecular mechanisms of invasion and metastasis of NSCLC were assessed. The expression of Oct‑4 and E‑cad was examined in 65 pathologically diagnosed cases of NSCLC using immunohistochemistry. The correlation between Oct‑4 and E‑cad, as well as the association with pathological grade and clinical staging were also analyzed. Fifteen cases of normal lung tissues served as the control. The positive expression of Oct‑4 and abnormal expression of E‑cad was higher in the NSCLC tissue compared to the normal lung tissue, and increased as NSCLC malignancy increased. The differences in each grade each stage were statistically significant (P<0.05). A correlation was identified between the abnormal expression of Oct‑4 and E‑cad (P<0.05, coefficient of contingency C=0.439). In conclusion, the expression of Oct‑4 promoted the epithelial‑mesenchymal transition in lung cancer.
View Figures
View References

Related Articles

Journal Cover

January-2016
Volume 11 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li L, Lv Y, Zhang Y, He L and Zhang H: Expression and clinical significance of Oct‑4 and E‑cad in non‑small‑cell lung cancer. Oncol Lett 11: 234-236, 2016
APA
Li, L., Lv, Y., Zhang, Y., He, L., & Zhang, H. (2016). Expression and clinical significance of Oct‑4 and E‑cad in non‑small‑cell lung cancer. Oncology Letters, 11, 234-236. https://doi.org/10.3892/ol.2015.3856
MLA
Li, L., Lv, Y., Zhang, Y., He, L., Zhang, H."Expression and clinical significance of Oct‑4 and E‑cad in non‑small‑cell lung cancer". Oncology Letters 11.1 (2016): 234-236.
Chicago
Li, L., Lv, Y., Zhang, Y., He, L., Zhang, H."Expression and clinical significance of Oct‑4 and E‑cad in non‑small‑cell lung cancer". Oncology Letters 11, no. 1 (2016): 234-236. https://doi.org/10.3892/ol.2015.3856